Back to Results
First PageMeta Content
Tyrosine kinase receptors / Protein domains / Fibroblast growth factor receptor / FLT3LG / Tyrosine kinase / Fibroblast growth factor / CD135 / Protein kinase / Biology / Cell signaling / Cell biology


Fragment Based Drug Discovery of Selective Inhibitors of Fibroblast Growth Factor Receptor (FGFR[removed]G. Saxty1, R. Akkari2, P. Angibaud2, J. Arts2, P. Benderitter2, V. Berdini1, P. Bonnet2, A. Cleasby1, I. Csoka2, W. E
Add to Reading List

Open Document

File Size: 125,54 KB

Share Result on Facebook

City

Newcastle upon Tyne / Beerse / Cambridge / /

Company

N.T. Thompson1 Therapeutics Ltd / Ligand / Novartis / Astex Therapeutics Limited. / /

Country

United Kingdom / Belgium / /

Facility

Paul O’Gorman Building / /

MedicalCondition

cancer / FGFR dependent tumours / tumours / /

Organization

3Northern Institute for Cancer Research / /

Person

Crystal Structures / Sang Hoon Lee / /

ProgrammingLanguage

C / /

ProvinceOrState

Florida / /

PublishedMedium

Cancer Research / /

Technology

Drug Discovery / drug design / Pharmacodynamics / X-ray / /

URL

www.astex-therapeutics.com / /

SocialTag